Sage Journals: Discover world-class research

Free access

Research article

First published 2023-2

Looking for biomarkers in interferon response pathway to predict response to oncolytic HSV-1 in breast cancer: An ex vivo study

Zahra Nejatipour, Ladan Teimoori-Toolabi, Ramin Sarrami Forooshani [...]

Cancer Biomarkers

Retricted access

Research article

First published 2006-01

Novel Three-Pronged Strategy to Enhance Cancer Cell Killing in Glioblastoma Cell Lines: Histone Deacetylase Inhibitor,Chemotherapy,and Oncolytic Adenovirus dl520

Alexa Bieler, Klaus Mantwill, Tanja Dravits [...]

Human Gene Therapy

Open access

Research article

First published 2023-05

A Winning New Combination? Toward Clinical Application in Oncology

Quratulain Maqsood, Aleena Sumrin, Maryam Iqbal [...]

Cancer Control

Open access

Research article

First published 2015-4

Therapeutic Effect on Bladder Cancer with a Conditionally Replicating Oncolytic Virus Derived from Type II Herpes Simplex Virus

Kwan Joong Joo, Hongtao Li, Xiaoliu Zhang [...]

Bladder Cancer

Retricted access

Research article

First published 2010-01

Evaluation of an Attenuated Vesicular Stomatitis Virus Vector Expressing Interferon-β for Use in Malignant Pleural Mesothelioma: Heterogeneity in Interferon Responsiveness Defines Potential Efficacy

Vassiliki Saloura, Liang-Chuan S. Wang, Zvi G. Fridlender [...]

Human Gene Therapy

Retricted access

Research article

First published 2011-09

Augmenting the Antitumor Effect of TRAIL by SOCS3 with Double-Regulated Replicating Oncolytic Adenovirus in Hepatocellular Carcinoma

Rui-Cheng Wei, Xin Cao, Jing-Hua Gui [...]

Human Gene Therapy

Retricted access

Research article

First published 2013-05

A Novel Armed Oncolytic Measles Vaccine Virus for the Treatment of Cholangiocarcinoma

Sebastian Lange, Johanna Lampe, Sascha Bossow [...]

Human Gene Therapy

Search results

Looking for biomarkers in interferon response pathway to predict response to oncolytic HSV-1 in breast cancer: An ex vivo study

Novel Three-Pronged Strategy to Enhance Cancer Cell Killing in Glioblastoma Cell Lines: Histone Deacetylase Inhibitor,Chemotherapy,and Oncolytic Adenovirus dl520

A Winning New Combination? Toward Clinical Application in Oncology

Therapeutic Effect on Bladder Cancer with a Conditionally Replicating Oncolytic Virus Derived from Type II Herpes Simplex Virus

Evaluation of an Attenuated Vesicular Stomatitis Virus Vector Expressing Interferon-β for Use in Malignant Pleural Mesothelioma: Heterogeneity in Interferon Responsiveness Defines Potential Efficacy

Augmenting the Antitumor Effect of TRAIL by SOCS3 with Double-Regulated Replicating Oncolytic Adenovirus in Hepatocellular Carcinoma

A Novel Armed Oncolytic Measles Vaccine Virus for the Treatment of Cholangiocarcinoma